IBI Lorenzini

IBI Lorenzini (Istituto Biochimico Italiano Giovanni Lorenzini) is a prominent Italian pharmaceutical company with over a century of expertise in the development and manufacturing of sterile injectable drugs. Founded in 1918, the company is a global leader in the production of beta-lactam antibiotics, specifically penicillins, and operates as a specialized Contract Development and Manufacturing Organization (CDMO). Its primary manufacturing site in Aprilia, Italy, is equipped with advanced technologies for lyophilization and aseptic filling, meeting stringent international regulatory standards including FDA and EMA. IBI Lorenzini provides a comprehensive range of services from active pharmaceutical ingredient (API) synthesis to finished dosage form production, supporting healthcare systems worldwide.